Genetic research
Researchers from the University of Washington have discovered that standard blood collection procedures can rapidly change the transcriptional and posttranscriptional landscapes of hematopoietic cells, leading to biased activation of specific biological pathways. This study highlights the potential confounding effects of technical artifacts in cancer genomics data and emphasizes the need
Scientists
Singapore scientists have made a groundbreaking discovery in the fight against aggressive breast cancer. A team of researchers at the Genome Institute of Singapore (GIS) and National University of Singapore (NUS) has found that the enzyme EZH2 may hold the key to developing more effective treatments for fast-spreading breast cancers,
Scientists
Research from Karolinska Institute in Stockholm, Sweden, has identified WRAP53 as a potential target for cancer therapy. According to the study, WRAP53 is an antisense transcript that regulates the p53 tumor suppressor, and its overexpression promotes cellular transformation and cancer cell survival. The study found that knockdown of the WRAP53
Genetic research
Scientists in Scotland have made a groundbreaking discovery in understanding the cellular function of the protein anterior gradient-2 (AGR2). AGR2 plays a crucial role in various biological systems, including goblet cell formation, limb regeneration, and inhibition of p53. Despite its importance, there has been a lack of well-validated binding proteins
Genetic research
Physician assistants (PAs) play a crucial role in primary and secondary cancer prevention, but a new study reveals that they often lack the necessary knowledge and skills to effectively assess and manage cancer in the primary care setting. L.R. Spence and colleagues at Baylor College of Medicine highlight the
Scientists
Researchers in Hong Kong, People's Republic of China, have uncovered the chemoprotective mechanism by which lycopene prevents polycyclic aromatic hydrocarbons (PAH)-induced carcinogenesis in the breast. Lycopene, a carotenoid widely distributed in fruit and vegetables, has been shown to inhibit phase 1 enzymes and induce phase 2 enzymes,
Scientists
Tumor cells in a state of hypoxia, characterized by a lack of oxygen, release soluble factors like vascular endothelial growth factor (VEGF) that induce angiogenesis - the formation of new blood vessels - to enhance tumor growth and facilitate metastasis. Researchers in Seoul, Korea, have discovered that thymosin beta-4 (TB4)
Scientists
Scientists in Hsinchu, Taiwan, have investigated the role of securin and gamma-H2AX in baicalein-induced cancer cell death. Baicalein, a natural flavonoid, reduced cell viability in various human cancer cell lines, including bladder, cervical, colon, and lung cancer cells. The study found that baicalein treatment significantly inhibited securin expression while elevating
Scientists
Recent research from the United States has shed new light on the crucial role of microRNAs in pituitary development, revealing a complex interplay of molecular mechanisms that have significant implications for our understanding of anterior pituitary hormones. According to a study published in the Journal of Biological Chemistry, a group
Scientists
Scientists in Seoul, Korea, have made significant strides in understanding the genetic factors influencing chemotherapy response in colorectal cancer patients. A groundbreaking report published in Cancer Science outlines a novel three-step process for identifying single nucleotide polymorphism (SNP) markers that predict chemoresponsiveness. This breakthrough has the potential to revolutionize cancer
Scientists
Scientists have detailed new data in the field of genetics and herpes simplex virus, revealing that RNA interference (RNAi) triggers from an oncolytic herpes simplex virus can lead to specific silencing in tumor cells in vitro and in vivo. The study, published in Bmc Cancer, aimed to express RNAi triggers
Scientists
Research from Peking University in Beijing, People's Republic of China, has shed new light on the genetic factors underlying Alzheimer's disease. Scientists have identified a human-specific de novo protein-coding gene, FLJ33706 (also known as C20orf203), which is associated with brain functions and has a unique evolutionary
